
Lacamas Laboratories
Get Full AccessDescription
- Lacamas Laboratories manufactures and delivers high quality products at the best price possible, on time every time. Our product list includes pharmaceutical intermediates such as Diboc (di-tert-butyl dicarbonate) as well as fine chemicals to customers outside the pharma industry.Lacamas Laboratories products are made at our plant located in Portland, Oregon on a scale that suits your needs. We can produce anything from quantities as small as 15 kgs needed for early clinical trials, to the many tons required for a full commercial launch.Lacamas Laboratories commitment to quality production standards is evident in all our production processes and laboratory procedures, from raw material procurement and testing, to the development and implementation of production and laboratory standard operating procedures, to final product testing.
-
Headquarters:Po Box 1831 , Fairview, Oregon, United States
More -
Phone Number:
-
Website: https://www.lacamaslabs.com
-
Employees:41
-
Revenue:$10 - 50M
-
Legal Name:Lacamas Laboratories
-
Lacamas Laboratories's Social Media
-
Is this data correct?
-
| NAICS Code: 336612 |
Show More
Frequently Asked Questions regarding Lacamas Laboratories
-
Where are Lacamas Laboratories's Headquarters?
Lacamas Laboratories's Headquarters are in Po Box 1831 ,Fairview,Oregon,United States
-
What is Lacamas Laboratories's official website?
Lacamas Laboratories's official website is https://www.lacamaslabs.com
-
What is Lacamas Laboratories's Revenue?
Lacamas Laboratories's revenue is $10 - 50M
-
What is Lacamas Laboratories's NAICS code?
Lacamas Laboratories's NAICS code is 336612
-
How many employees are working in Lacamas Laboratories
Lacamas Laboratories has 41 employees
-
What is Lacamas Laboratories's Industry?
Lacamas Laboratories is in the industry of Chemicals
-
Who is Lacamas Laboratories's CEO?
Lacamas Laboratories's CEO is Allen Erickson
-
Who is Lacamas Laboratories's Chief Technology Officer?
Lacamas Laboratories's Chief Technology Officer is Michael Ellis